Study Title: Efficacy and Safety of Pasireotide Administered Monthly in Patients with Cushing's Disease/ “Cushing Study”
Summary: This is an interventional, randomized, double-blind, multicenter, phase III study to evaluate the safety and efficacy of 2 dosing regiments of Pasireotide long acting release (LAR) for treatment in patients with Cushing's disease.
Recruting Status: Enrollment is open
To learn more about this clinical trial please visit: http://clinicaltrials.gov/.
If interested, contact the Study Coordinator at 410-502-0033 or Roberto Salvatori, MD, Principal Investigator via phone at 410-955-3921.